Does TOFACITINIB Cause Joint effusion? 520 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 520 reports of Joint effusion have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
520
Reports of Joint effusion with TOFACITINIB
0.3%
of all TOFACITINIB reports
23
Deaths
123
Hospitalizations
How Dangerous Is Joint effusion From TOFACITINIB?
Of the 520 reports, 23 (4.4%) resulted in death, 123 (23.7%) required hospitalization, and 48 (9.2%) were considered life-threatening.
Is Joint effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 520 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Joint effusion?
ADALIMUMAB (1,367)
METHOTREXATE (917)
ETANERCEPT (826)
LEFLUNOMIDE (407)
TOCILIZUMAB (391)
HYDROXYCHLOROQUINE (380)
INFLIXIMAB (372)
RITUXIMAB (368)
PREDNISONE (357)
ABATACEPT (349)
Which TOFACITINIB Alternatives Have Lower Joint effusion Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN